ResearchMoz

Top 200 Industrial Robotics (Global)

Plimsoll Publishing Ltd.
Published Date » 2012-07-01
No. Of Pages » 305
   
This report is an in-depth financial evaluation of the GlobalIndustrial Robotics. Using the unique Plimsoll method of analysis, each of the top 200 companies included is individually assessed and ranked against each other and compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report:     23 of the 200 companies analysed have been rated as Danger   42 companies are ripe for takeover    28 companies achieved greater than 10% increase in sales last year.   10 companies made a pre-tax loss.    70 companies saw sales fall last year ....
Table Of Contents

This extensive report is broken into two parts:


1. A complete financial assessment of the market, based on the companies analysed
2. An individual financial performance analysis of each company (2 pages per company)

Specific areas included in the market assessment include;

Section 1 - Best Trading Partners (based on commercial and financial strength)

1.1a Best Trading Partners definition and industry top 5 list
1.1b Performance matrix (Financial Strength Vs Sales Growth)
1.1c List of Best Trading Partners in the industry

Section 2 - Sales & Market Performance

2.1 Sales Growth
2.1a 4 year trend analysis
2.1b Industry Average Sales Growth
2.1c Sales Growth Ranking Table
2.1d Top 50 Companies ranked by Market Share
2.2 Sales Return on Assets
2.2a 4 year trend analysis
2.2b Sales return on total assets
2.2c Sales return on assets ranking table
2.2d Top 50 companies sales return on assets

Section 3 Profitability

3.1 Pre-tax profit margin
3.1a Pre-tax profit margin 4 year trend analysis
3.1b Industry Average pre-tax profit margin
3.1c Pre-tax profit margin ranking table
3.1d Top 50 companies actual pre-tax profit
3.2 - Pre-tax profit return on total assets
3.2a - Pre-tax profit return on total assets 4 year trend analysis
3.2b Industry average pre-tax profit return on total assets
3.2c Pre-tax profit return on total assets ranking table
3.3 - Profitability
3.3a Profitability industry average

4. 0 How to Use

5.0 Individual Company Analysis

The individual company assessment gives a complete financial picture of each company listed, including a narrative summary of the analysis. One of our key indicators is the Plimsoll Chart which combines several performance figures to give an overall measurement of the financial strength of any company. The Plimsoll chart is complied through the analysis of several different areas, including;

Sales Growth, Trading Stability, Profitability, Working Capital, Gearing and Immediate Liquidity

As all measurements are standardised, in one report you can quickly compare like with like for every major company in your industry. The accounts of each company appear in its own currency and US$ to allow comparison.

Each individual company analysis includes:

  • A full four year financial assessment, Debtor days analysis, Latest sales/profitability rankings. 
  • Employee Performance Analysis, Comparisons against industry average.
  • Overall company financial rating as read in the Plimsoll Chart, Industry ranking matrix.
  • Company analysis written summary.
Other information in the report includes;

  • Details of the Plimsoll Model
  • Definition of Terms
  • List of Shareholders
  • Global Index by region
  • Ranking Analysis by sales/profits
  • Companies considered but not included
  • Index of companies


List of Tables

NA

List of Figures

NA

Upcoming Reports:

Intravenous Immunoglobulin (IVIG) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Intravenous immunoglobulin (IVIG)is a blood product administered intravenously. These are mainly used for the treatment of immune deficiencies, autoimmune diseases and acute infections. IVIG is given as a plasma protein replacement therapy for immune deficient patients (i.e. patients have decreased or abolished antibody productions). Intravenous immunoglobulin is administered to maintain sufficient antibody levels of a patient in order to prevent infections or to enhance immunity. There are different intravenous immunoglobulinproducts availableas trade names in the market namely Gamunex,...
Herbal Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The market of herbal supplements is witnessing a steady growth since the last decade mainly due to the growing awareness among the consumers of the effect of consuming synthetic supplements. Herbal supplements market was not even affected by the financial meltdown during 2009-10. Some of the major factors driving the market for global supplements market include the growing global ageing population and the growing concern among consumer to stay healthy and fit.  During the recession period, when every other market was experiencing the heat of financial meltdown herbal...
Medical Practice Management Software Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Medical practice management software (PMS) assists in managing a healthcare business, starting from the scheduling of patients to the generation of periodic reports. Therefore, selecting the appropriate medical practice management system is crucial in any medical practice. The onus of selecting the practice management software and managing it lies with the IT manager in any healthcare providing institution. The medical practice management software market helps in integration of electronic health records (EHR), in providing interoperability solutions, and assists in the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

High-sodium Diet Increases Risks of Cardiovascular Diseases in Type 2 Diabetics
Jul 24, 2014  
A new research has found relation between the amount of salt in diet of diabetics and their chances of suffering from cardiovascular diseases. The research has stated that diabetics who have a high-salt diet are on a higher risk of having a chronic heart disease as compared to the ones who eat less salt.  The study’s findings provide evidences that support the benefits of a...
Strides Arcolab Bags USFDA Approval for Transplant Drug
Jul 24, 2014  
Indian pharmaceutical company Strides Arcolab has received the approval of the USFDA to sell its transplant drug Tacrolimus in the US market. The capsule is an immune-suppressant that is used for preventing organ rejection that may occur in transplant surgeries of organs such as kidneys, heart or liver in some patients.  USFDA has allowed the sale of the tablets in 5 mg, 1 mg and 0.5...
Chinese manufacturing gauge gets a hike after months
Jul 24, 2014  
China manufacturing gauge has climbed to its 18-month high this month, which has boosted the government’s chance of meeting the target for economic growth set for 2014, by a percentage of 7.5. The Purchasing Managers Index (PMI) preliminary from Markit Economics and HSBC Holdings Plc was at 52.0 and its has topped the 51.0 median estimate. These numbers indicate an above 50 mark. The...
Paracetamol doesn’t speed recovery or reduce low back pain: Study
Jul 24, 2014  
Paracetamol, which has long since been prescribed as a painkiller for severe low back pain, is no better than placebo; findings of a recent study in Australia have shown. The trial that was published on Thursday found that the universally recommended painkiller neither speeds recovery nor reduces the pain. Paracetamol is merely acts as a placebo or dummy pills doing nothing to ease the...
Early Treatment to Cure HIV virus Might not be Effective
Jul 23, 2014  
According to a research study, the virus of AIDS, HIV has the capacity of creating invulnerable strongholds in the host’s body rapidly. This has dashed hopes of early treatment for the condition, which might have been helpful to cure the virus. In one case, a baby was thought to be cured with the new treatment after its birth, however, the virus emerged couple of years later. A...